NCT01756651View on ClinicalTrials.gov

Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 10, 2016

Study Completion Date

May 10, 2016

Conditions
Other Acute PainPain Experienced During Cystoscopy
Interventions
DRUG

Fentanyl pectin

comparison of Intranasal fentanyl 100mcg vs 200 mcg.

Trial Locations (1)

90502

Urology Clinic, Harbor-UCLA Medical Center, Torrance

Sponsors

Collaborators (1)

Depomed
All Listed Sponsors
collaborator

Depomed

INDUSTRY

lead

Richard C Reznichek, MD

OTHER

NCT01756651 - Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures | Biotech Hunter | Biotech Hunter